[BCG vaccination, cancer and infectious mononucleosis. A retrospective study of hospitalized patients].
A retrospective study (1966--1976) of patients hospitalized for cancer was carried out to determine a possible relationship with BCG vaccination, with a control group matched for age and sex and a similar study concerning infectious mononucleosis. Among 105 patients with cancer, 54 (51.42%) had been previously vaccinated with BCG, 56 (53.33%) in the control group, and 22 (33.84%) among the 65 patients with infectious mononucleosis (p less than 0.05, x2). The mean age on admission for cancer or infectious mononucleosis among vaccinees is significantly older than among non-vaccinees, suggesting a transient protection afforded by vaccination. These results need to be confirmed by a prospective study with Epstein-Barr virus serology.
D000367:Age Factors; D000368:Aged; D001500:BCG Vaccine; D005260:Female; D006801:Humans; D007244:Infectious Mononucleosis / Q000453:epidemiology* / Q000276:immunology; D008297:Male; D009369:Neoplasms / Q000453:epidemiology* / Q000276:immunology; D012189:Retrospective Studies; D012737:Sex Factors
D001500:BCG Vaccine
Vaccination BCG, cancer et mononucléose infectieuse. Etude rétrospective de patients hospitalisés.